These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25998434)

  • 1. Update on antimicrobial resistance in Clostridium difficile.
    Gao Q; Huang HH
    Yi Chuan; 2015 May; 37(5):458-64. PubMed ID: 25998434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
    Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.
    Ackermann G; Degner A; Cohen SH; Silva J; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):599-603. PubMed ID: 12615860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
    Huang H; Fang H; Weintraub A; Nord CE
    Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Banawas SS
    Biomed Res Int; 2018; 2018():8414257. PubMed ID: 29682562
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular and epidemiologic study of Clostridium difficile reveals unusual heterogeneity in clinical strains circulating in different regions in Portugal.
    Santos A; Isidro J; Silva C; Boaventura L; Diogo J; Faustino A; Toscano C; Oleastro M
    Clin Microbiol Infect; 2016 Aug; 22(8):695-700. PubMed ID: 27091093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in Clostridium difficile.
    Huang H; Weintraub A; Fang H; Nord CE
    Int J Antimicrob Agents; 2009 Dec; 34(6):516-22. PubMed ID: 19828299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibilities and molecular characterization of toxin-positive Clostridium difficile isolates: the first report on the presence of hypervirulent strains from Turkey].
    Salman E; Levent B; Karahan ZC
    Mikrobiyol Bul; 2017 Jul; 51(3):236-246. PubMed ID: 28929960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of Clostridium difficile in Scotland.
    Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
    J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin.
    Álvarez-Pérez S; Blanco JL; Harmanus C; Kuijper E; García ME
    Vet Microbiol; 2017 Feb; 199():15-22. PubMed ID: 28110780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment.
    Tian TT; Zhao JH; Yang J; Qiang CX; Li ZR; Chen J; Xu KY; Ciu QQ; Li RX
    PLoS One; 2016; 11(3):e0151964. PubMed ID: 27011211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
    Baines SD; O'Connor R; Freeman J; Fawley WN; Harmanus C; Mastrantonio P; Kuijper EJ; Wilcox MH
    J Antimicrob Chemother; 2008 Nov; 62(5):1046-52. PubMed ID: 18693234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Lim SC; Androga GO; Knight DR; Moono P; Foster NF; Riley TV
    Int J Antimicrob Agents; 2018 Sep; 52(3):411-415. PubMed ID: 29802886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
    Bourgault AM; Lamothe F; Loo VG; Poirier L;
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of Clostridium difficile isolated in Japan.
    Kunishima H; Chiba J; Saito M; Honda Y; Kaku M
    J Infect Chemother; 2013 Apr; 19(2):360-2. PubMed ID: 23338015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.